মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

allergan new zealand ltd - disodium edetate dihydrate 0.1%{relative}; octoxinol 0.035%{relative} (0.05%w/v of a 70%w/w solution); potassium sorbate 0.147%{relative} - contact lens solution - active: disodium edetate dihydrate 0.1%{relative} octoxinol 0.035%{relative} (0.05%w/v of a 70%w/w solution) potassium sorbate 0.147%{relative} excipient: borax boric acid hydrochloric acid hyetellose purified water sodium chloride sodium hydroxide

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

allergan new zealand ltd - disodium edetate dihydrate 0.2%{relative}; octoxinol 0.142%; potassium sorbate 0.13% - contact lens solution - active: disodium edetate dihydrate 0.2%{relative} octoxinol 0.142% potassium sorbate 0.13% excipient: boric acid hydrochloric acid hyetellose purified water sodium chloride sodium hydroxide

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.025%; potassium sorbate 0.13% (+ 10% overage = 0.147%w/v); sodium chloride 0.43% - contact lens solution - active: disodium edetate dihydrate 0.025% potassium sorbate 0.13% (+ 10% overage = 0.147%w/v) sodium chloride 0.43% excipient: borax boric acid hydrochloric acid purified water sodium hydroxide

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - disodium edetate -

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

morgan and hall ltd - dibasic sodium phosphate 0.018%{relative}; disodium edetate dihydrate 0.01%{relative}; monobasic sodium phosphate dihydrate 0.33%{relative}; sodium chloride 0.827%{relative}; thiomersal 0.002%{relative} - contact lens solution - active: dibasic sodium phosphate 0.018%{relative} disodium edetate dihydrate 0.01%{relative} monobasic sodium phosphate dihydrate 0.33%{relative} sodium chloride 0.827%{relative} thiomersal 0.002%{relative}

ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - phosphate buffer saline solution (vet.) - sterile solution (intranasal/intraocular) - each ml contains: sodium chloride ....................7.65 mg disodium phosphate dihydrate .................. 0.72 mg disodium edetate......................... 0.50 mg potassium dihydrogen phosphate ............................ 0.37 mg patent blue v................................... 0.17 mg water for injection ..................... 990.59 mg

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

gambro lundia ab - disodium phosphate dihydrate; magnesium chloride hexahydrate; sodium hydrogen carbonate; sodium chloride; potassium chloride - solution for haemodialysis/haemofiltration - . - hemofiltrates

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

avkare - balsalazide disodium (unii: 1xl6bji034) (balsalazide - unii:p80al8j7zp) - balsalazide disodium 750 mg - balsalazide disodium capsules are indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. safety and effectiveness of balsalazide beyond 8 weeks in children (ages 5 to 17 years) and 12 weeks in adults have not been established. patients with hypersensitivity to salicylates or to any of the components of balsalazide disodium capsules or balsalazide metabolites. hypersensitivity reactions may include, but are not limited to the following: anaphylaxis, bronchospasm, and skin reaction. pregnancy category b. reproduction studies were performed in rats and rabbits at oral doses up to 2 g/kg/day, 2.4 and 4.7 times the recommended human dose based on body surface area for the rat and rabbit, respectively, and revealed no evidence of impaired fertility or harm to the fetus due to balsalazide disodium. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response,

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

oceanside pharmaceuticals - balsalazide disodium (unii: 1xl6bji034) (balsalazide - unii:p80al8j7zp) - balsalazide disodium 750 mg - balsalazide disodium capsule is indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. safety and effectiveness of balsalazide disodium capsules beyond 8 weeks in children (ages 5-17 years) and 12 weeks in adults have not been established. patients with hypersensitivity to salicylates or to any of the components of balsalazide disodium capsules or balsalazide metabolites. hypersensitivity reactions may include, but are not limited to the following: anaphylaxis, bronchospasm, and skin reaction. reproduction studies were performed in rats and rabbits at oral doses up to 2 g/kg/day, 2.4 and 4.7 times the recommended human dose based on body surface area for the rat and rabbit, respectively, and revealed no evidence of impaired fertility or harm to the fetus due to balsalazide disodium. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, this